×
About 107 results

ALLMedicine™ Gynecologic Cancers Center

Research & Reviews  45 results

Long Non-coding RNA NEAT1 as an Emerging Biomarker in Breast and Gynecologic Cancers: a...
https://doi.org/10.1007/s43032-021-00481-x 10.1093/nar/gky1031 10.1101/gr.132159.111 10.1128/MCB.10.1.28 10.3389/fimmu.2018.02512 10.1038/nature20149 10.3892/or.2016.5236 10.1038/onc.2017.184 10.1371/journal.pone.0053823 10.1111/imm.12121 10.1093/nar/gky1190 10.1093/nar/gkx1224 10.18632/aging.101341 10.1016/j.ccell.2016.03.010 10.1038/s41419-018-0282-x 10.1038/s12276-018-0188-9 10.1146/annurev-immunol-041015-055459 10.1161/CIRCRESAHA.116.302521 10.1111/jcmm.13866 10.2147/CIA.S107037 10.1016/j.ncrna.2018.11.003 10.1242/dev.110544 10.1016/j.placenta.2013.11.003 10.18632/oncotarget.11364 10.1038/s41467-019-09482-6 10.1038/s41598-017-10001-0 10.2147/OTT.S240769 10.1038/s41419-019-1513-5 10.1101/gr.7.7.725 10.1101/gr.087775.108 10.1073/pnas.0807899106 10.1038/nrm1172 10.1016/S0960-9822(01)00632-7 10.1016/j.cell.2018.11.027 10.1016/j.molcel.2009.06.027 10.1038/s41598-020-57759-4 10.1091/mbc.e06-09-0846 10.1016/j.cell.2005.08.033 10.1101/cshperspect.a000687 10.1093/nar/gkw271 10.1091/mbc.e05-06-0587 10.1186/1471-2164-8-39 10.1002/ar.a.20336 10.1016/j.molcel.2009.01.026 10.1007/978-94-017-7417-8_2 10.1038/ncb2140 10.1038/emboj.2012.251 10.1091/mbc.e10-08-0690 10.1091/mbc.e13-09-0558 10.1261/rna.059477.116 10.1083/jcb.201011110 10.15252/embj.201695848 10.1093/nar/gky046 10.1111/cpr.12329 10.1016/j.molcel.2018.05.019 10.1038/onc.2014.378 10.1038/nm.4135 10.1016/j.gendis.2017.11.003 10.3389/fgene.2018.00471 10.1158/1078-0432.CCR-17-0605 10.1002/jcp.26470 10.1172/JCI94233 10.1186/s13058-015-0557-4 10.1159/000485344 10.1016/j.ijbiomac.2017.07.053 10.1186/s12885-018-4845-0 10.1038/nrg.2016.20 10.1002/1878-0261.12472 10.3233/CBM-170027 10.1016/j.abb.2016.12.011 10.3390/ijms20153616 10.1002/jcp.29225 10.1038/nature22992 10.18632/oncotarget.17356 10.1146/annurev-pharmtox-010716-104846 10.1007/s13277-015-3843-y 10.3892/ol.2016.4738 10.18632/oncotarget.4737 10.1002/cam4.710 10.1038/s41419-018-0908-z 10.2147/OTT.S147586 10.2147/ott.s142446 10.1111/cas.13647 10.3322/caac.21442 10.1016/j.biopha.2016.09.008 10.1186/s13046-019-1306-9 10.1007/s00404-017-4365-1 10.1002/iub.1959 10.2478/raon-2019-0051 10.3322/caac.21590 10.4103/0366-6999.239308 10.1039/C9RA07039G 10.1002/jcp.28538 10.1139/bcb-2018-0111 10.1038/srep45283 10.3390/cells9030632 10.2147/OTT.S220306 10.3892/or.2016.5075
Reproductive Sciences (Thousand Oaks, Calif.); Thankachan S, Bhardwaj BK et. al.

Feb 11th, 2021 - Long non-coding RNAs (lncRNAs) are emerging regulators of cellular pathways, especially in cancer development. Among the lncRNAs, nuclear paraspeckle assembly transcript 1 (NEAT1) forms a scaffold for a nuclear body; the paraspeckle and aberrant e...

Deciphering the Role of Human Gastrointestinal Microbiota in the Pathogenesis of Vagina...
https://doi.org/10.1615/JEnvironPatholToxicolOncol.2020035637
Journal of Environmental Pathology, Toxicology and Oncolo... Wang J, Yang Z et. al.

Jan 3rd, 2021 - The human microbiota typically contains symbionts and supports the host, although it can be commensal or reciprocal and pathogenic in its host function, immunity, and diet. Modern studies indicate that perturbations in the microbiome may be presen...

Risks of Second Primary Gynecologic Cancers following Ovarian Cancer Treatment in Asian...
https://doi.org/10.1158/1055-9965.EPI-20-0095
Cancer Epidemiology, Biomarkers & Prevention : a Publicat... Mukand NH, Zolekar A et. al.

Aug 28th, 2020 - The differential occurrence of second primary cancers by race following ovarian cancer is poorly understood. Our objective was to determine the incidence of second primary gynecologic cancers (SPGC) following definitive therapy for ovarian cancer....

Incidence Rates of Gynecologic Cancers in the U.S. Active Duty Military Population.
https://doi.org/10.1093/milmed/usaa083
Military Medicine; Owens S, Blando T et. al.

Jun 3rd, 2020 - Despite an increasing number of female service members, incidence rates of gynecologic cancers (other than cervical cancer) have not been previously documented in the U.S. active duty military population. This study sought to determine the inciden...

End-of-life symptoms and interventions among women with gynecologic cancers in a tertia...
https://doi.org/10.1136/ijgc-2019-000338
International Journal of Gynecological Cancer : Official ... Sompratthana T, Phoolcharoen N et. al.

May 12th, 2019 - Studies have shown improved patient quality of life with supportive care rather than aggressive treatment at the end of life. This study evaluated the symptoms that patients in Thailand with gynecologic cancers experienced and the interventions th...

see more →

Clinicaltrials.gov  57 results

Long Non-coding RNA NEAT1 as an Emerging Biomarker in Breast and Gynecologic Cancers: a...
https://doi.org/10.1007/s43032-021-00481-x 10.1093/nar/gky1031 10.1101/gr.132159.111 10.1128/MCB.10.1.28 10.3389/fimmu.2018.02512 10.1038/nature20149 10.3892/or.2016.5236 10.1038/onc.2017.184 10.1371/journal.pone.0053823 10.1111/imm.12121 10.1093/nar/gky1190 10.1093/nar/gkx1224 10.18632/aging.101341 10.1016/j.ccell.2016.03.010 10.1038/s41419-018-0282-x 10.1038/s12276-018-0188-9 10.1146/annurev-immunol-041015-055459 10.1161/CIRCRESAHA.116.302521 10.1111/jcmm.13866 10.2147/CIA.S107037 10.1016/j.ncrna.2018.11.003 10.1242/dev.110544 10.1016/j.placenta.2013.11.003 10.18632/oncotarget.11364 10.1038/s41467-019-09482-6 10.1038/s41598-017-10001-0 10.2147/OTT.S240769 10.1038/s41419-019-1513-5 10.1101/gr.7.7.725 10.1101/gr.087775.108 10.1073/pnas.0807899106 10.1038/nrm1172 10.1016/S0960-9822(01)00632-7 10.1016/j.cell.2018.11.027 10.1016/j.molcel.2009.06.027 10.1038/s41598-020-57759-4 10.1091/mbc.e06-09-0846 10.1016/j.cell.2005.08.033 10.1101/cshperspect.a000687 10.1093/nar/gkw271 10.1091/mbc.e05-06-0587 10.1186/1471-2164-8-39 10.1002/ar.a.20336 10.1016/j.molcel.2009.01.026 10.1007/978-94-017-7417-8_2 10.1038/ncb2140 10.1038/emboj.2012.251 10.1091/mbc.e10-08-0690 10.1091/mbc.e13-09-0558 10.1261/rna.059477.116 10.1083/jcb.201011110 10.15252/embj.201695848 10.1093/nar/gky046 10.1111/cpr.12329 10.1016/j.molcel.2018.05.019 10.1038/onc.2014.378 10.1038/nm.4135 10.1016/j.gendis.2017.11.003 10.3389/fgene.2018.00471 10.1158/1078-0432.CCR-17-0605 10.1002/jcp.26470 10.1172/JCI94233 10.1186/s13058-015-0557-4 10.1159/000485344 10.1016/j.ijbiomac.2017.07.053 10.1186/s12885-018-4845-0 10.1038/nrg.2016.20 10.1002/1878-0261.12472 10.3233/CBM-170027 10.1016/j.abb.2016.12.011 10.3390/ijms20153616 10.1002/jcp.29225 10.1038/nature22992 10.18632/oncotarget.17356 10.1146/annurev-pharmtox-010716-104846 10.1007/s13277-015-3843-y 10.3892/ol.2016.4738 10.18632/oncotarget.4737 10.1002/cam4.710 10.1038/s41419-018-0908-z 10.2147/OTT.S147586 10.2147/ott.s142446 10.1111/cas.13647 10.3322/caac.21442 10.1016/j.biopha.2016.09.008 10.1186/s13046-019-1306-9 10.1007/s00404-017-4365-1 10.1002/iub.1959 10.2478/raon-2019-0051 10.3322/caac.21590 10.4103/0366-6999.239308 10.1039/C9RA07039G 10.1002/jcp.28538 10.1139/bcb-2018-0111 10.1038/srep45283 10.3390/cells9030632 10.2147/OTT.S220306 10.3892/or.2016.5075
Reproductive Sciences (Thousand Oaks, Calif.); Thankachan S, Bhardwaj BK et. al.

Feb 11th, 2021 - Long non-coding RNAs (lncRNAs) are emerging regulators of cellular pathways, especially in cancer development. Among the lncRNAs, nuclear paraspeckle assembly transcript 1 (NEAT1) forms a scaffold for a nuclear body; the paraspeckle and aberrant e...

Deciphering the Role of Human Gastrointestinal Microbiota in the Pathogenesis of Vagina...
https://doi.org/10.1615/JEnvironPatholToxicolOncol.2020035637
Journal of Environmental Pathology, Toxicology and Oncolo... Wang J, Yang Z et. al.

Jan 3rd, 2021 - The human microbiota typically contains symbionts and supports the host, although it can be commensal or reciprocal and pathogenic in its host function, immunity, and diet. Modern studies indicate that perturbations in the microbiome may be presen...

PORTEC-3: Effect of Molecular Classification of Endometrial Cancer on Outcomes With Adjuvant Therapy
https://ascopost.com/issues/september-10-2020-supplement-gynecologic-cancers-almanac/effect-of-molecular-classification-of-endometrial-cancer-on-outcomes-with-adjuvant-therapy/

Sep 9th, 2020 - Update on Treatments Across Gynecologic Cancers Ovarian cancer is associated with the highest risk of mortality among the five most common gynecologic cancers (cervical, ovarian, uterine [endometrial], vaginal, and vulvar) in the United States; in...

Risks of Second Primary Gynecologic Cancers following Ovarian Cancer Treatment in Asian...
https://doi.org/10.1158/1055-9965.EPI-20-0095
Cancer Epidemiology, Biomarkers & Prevention : a Publicat... Mukand NH, Zolekar A et. al.

Aug 28th, 2020 - The differential occurrence of second primary cancers by race following ovarian cancer is poorly understood. Our objective was to determine the incidence of second primary gynecologic cancers (SPGC) following definitive therapy for ovarian cancer....

Incidence Rates of Gynecologic Cancers in the U.S. Active Duty Military Population.
https://doi.org/10.1093/milmed/usaa083
Military Medicine; Owens S, Blando T et. al.

Jun 3rd, 2020 - Despite an increasing number of female service members, incidence rates of gynecologic cancers (other than cervical cancer) have not been previously documented in the U.S. active duty military population. This study sought to determine the inciden...

see more →

News  3 results

Novel Handheld Device Detects High-Risk HPV in 2 Hours
https://www.medscape.com/viewarticle/910609

Mar 18th, 2019 - HONOLULU — A novel handheld device that incorporates artificial intelligence detects high-risk human papillomavirus (HPV) strains 16 and 18 within 2 hours and performs as well as biopsy, which can require 2 weeks for results to be returned. Anothe...

Novel Handheld Device Detects High-Risk HPV in 2 Hours
https://www.staging.medscape.com/viewarticle/910609

Mar 18th, 2019 - HONOLULU — A novel handheld device that incorporates artificial intelligence detects high-risk human papillomavirus (HPV) strains 16 and 18 within 2 hours and performs as well as biopsy, which can require 2 weeks for results to be returned. Anothe...

see more →

Patient Education  1 results see all →